Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zoya Jelovečki – Dokić"'
Autor:
Filip Radevski, Zoya Jelovečki-Dokić, Marina Madunić, Slaven Gojković, Helena Žižek, Tajana Đurašin, Vilim Dretar
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
INTRODUCTION We sought to determine whether stable gastric pentadecapeptide BPC 157 mitigates lithium intoxication in rats. METHODS: Lithium was applied at 500 mg/kg/day, intraperitoneally, once daily throughout 3 subsequent days. Medication used (in
Autor:
Pavla Peraić, Josh Fry, Mariam Samara, Marko Belamarić, Marina Madunić, Hrvoje Vraneš, Zoya Jelovečki-Dokić
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
BPC 157 (LD1 not achieved) was implemented as an anti-ulcer peptide in IBD trials and now in a multiple sclerosis trial. BPC 157 maintained corneal transparency, total debridement of corneal epithelium cured with no corneal neovascularization, perfor
Autor:
Slaven Gojković, Hrvoje Vraneš, Zoya Jelovečki – Dokić, Oliver Marcel Koltay, Will Migo, Dominik Malekinušić
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Portal hypertension, aortal hypotension, caval hypertension
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Pentadecapeptide BPC 157 is intraduced as therapy in a suprahepatic inferior caval vein (ICV) occlusion 15 min, 24h, 48h after complete ICV ligation. Suprahepatic ICV complications that were counteracted by BPC 157 included esophageal bleeding, sever